Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...

Low tax along with the quality of life and a drop in crime are drawing white-collar industries to the Florida city ...

In China, the world’s second largest pharmaceutical market, Kite will form a 50/50 joint venture with Fosun Pharma, based in Shanghai, to develop, manufacture and market lead clinical ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised ...

AS the Rotary Club of Georgetown Central (RCGC) celebrates another year of impactful service, the organisation is spotlighting four major projects that ...

MycoWorks is proud to announce the exclusive launch of its pioneering biomaterial’s new collectible design collection Reishi™ ...

Despite advances, the roles of genetics and microenvironment in CLL are not fully understood, and curative treatments may ...

Kite Realty Group (NYSE: KRG), a real estate investment trust (REIT), is a premier owner and operator of open-air shopping centers and mixed-use assets. The Company’s primarily grocery-anchored ...